Profarma Distribuidora de Produtos Farmacêuticos S.A. (PFRM3.SA)
BRL 8.09
(0.0%)
BRL 8.09
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 398.41 Million BRL | 7.66% |
| 2022 | 380.43 Million BRL | 47.6% |
| 2021 | 226.44 Million BRL | 22.93% |
| 2020 | 199.27 Million BRL | -16.9% |
| 2019 | 206.75 Million BRL | 244.58% |
| 2018 | 75.74 Million BRL | 982.52% |
| 2017 | 18.65 Million BRL | -94.8% |
| 2016 | 101.23 Million BRL | 102.18% |
| 2015 | 61.88 Million BRL | 84.43% |
| 2014 | 33.55 Million BRL | -58.62% |
| 2013 | 81.07 Million BRL | -12.11% |
| 2012 | 84.82 Million BRL | 10.2% |
| 2011 | 69.22 Million BRL | 13.02% |
| 2010 | 63.17 Million BRL | -28.85% |
| 2009 | 96.45 Million BRL | 22.77% |
| 2008 | 77.83 Million BRL | -5.82% |
| 2007 | 90.03 Million BRL | 63.69% |
| 2006 | 55 Million BRL | 9.27% |
| 2005 | 50.33 Million BRL | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 128.52 Million BRL | 59.72% |
| 2024 Q1 | 81.77 Million BRL | -27.01% |
| 2024 Q3 | 136.98 Million BRL | -0.95% |
| 2023 Q2 | 94.59 Million BRL | 48.01% |
| 2023 Q3 | 107.92 Million BRL | 14.09% |
| 2023 FY | - BRL | 7.66% |
| 2023 Q4 | 100.49 Million BRL | -6.89% |
| 2023 Q1 | 63.91 Million BRL | -11.71% |
| 2022 FY | - BRL | 47.6% |
| 2022 Q1 | 50.39 Million BRL | -8.47% |
| 2022 Q2 | 146.1 Million BRL | 189.91% |
| 2022 Q3 | 97.58 Million BRL | -33.21% |
| 2022 Q4 | 72.39 Million BRL | -25.82% |
| 2021 Q2 | 79.97 Million BRL | 97.19% |
| 2021 FY | - BRL | 22.93% |
| 2021 Q3 | 72.46 Million BRL | -9.38% |
| 2021 Q4 | 55.05 Million BRL | -24.02% |
| 2021 Q1 | 40.55 Million BRL | -33.5% |
| 2020 Q2 | 36.7 Million BRL | -13.22% |
| 2020 Q1 | 42.29 Million BRL | -66.62% |
| 2020 Q3 | 65.1 Million BRL | 77.4% |
| 2020 Q4 | 60.98 Million BRL | -6.34% |
| 2020 FY | - BRL | -16.9% |
| 2019 FY | - BRL | 244.58% |
| 2019 Q1 | 30.61 Million BRL | 7.15% |
| 2019 Q2 | 47.99 Million BRL | 56.8% |
| 2019 Q3 | 47.91 Million BRL | -0.18% |
| 2019 Q4 | 126.68 Million BRL | 164.43% |
| 2018 FY | - BRL | 982.52% |
| 2018 Q4 | 28.56 Million BRL | 132.86% |
| 2018 Q3 | 12.26 Million BRL | -49.28% |
| 2018 Q2 | 24.18 Million BRL | 248.2% |
| 2018 Q1 | 6.94 Million BRL | -42.31% |
| 2017 Q4 | 12.04 Million BRL | 194.25% |
| 2017 Q3 | -12.77 Million BRL | -175.25% |
| 2017 Q2 | 16.97 Million BRL | 351.93% |
| 2017 Q1 | 3.75 Million BRL | -90.68% |
| 2017 FY | - BRL | -94.8% |
| 2016 Q1 | 15.58 Million BRL | 5.25% |
| 2016 Q3 | 24.84 Million BRL | -50.15% |
| 2016 FY | - BRL | 102.18% |
| 2016 Q4 | 40.3 Million BRL | 62.2% |
| 2016 Q2 | 49.84 Million BRL | 219.88% |
| 2015 Q2 | 23.41 Million BRL | 288.26% |
| 2015 Q4 | 14.8 Million BRL | -14.5% |
| 2015 Q3 | 17.31 Million BRL | -26.04% |
| 2015 FY | - BRL | 84.43% |
| 2015 Q1 | 6.03 Million BRL | 5.51% |
| 2014 Q1 | 7.62 Million BRL | -29.0% |
| 2014 Q2 | 23.74 Million BRL | 211.3% |
| 2014 Q3 | 2.28 Million BRL | -90.38% |
| 2014 Q4 | 5.71 Million BRL | 150.11% |
| 2014 FY | - BRL | -58.62% |
| 2013 FY | - BRL | -12.11% |
| 2013 Q2 | 26.41 Million BRL | 40.42% |
| 2013 Q1 | 18.8 Million BRL | -38.1% |
| 2013 Q4 | 10.74 Million BRL | -60.55% |
| 2013 Q3 | 27.23 Million BRL | 3.12% |
| 2012 Q3 | 19.59 Million BRL | -42.33% |
| 2012 FY | - BRL | 10.2% |
| 2012 Q2 | 33.97 Million BRL | 45.48% |
| 2012 Q1 | 23.35 Million BRL | -51.04% |
| 2012 Q4 | 30.38 Million BRL | 55.08% |
| 2011 Q4 | 47.7 Million BRL | 210.67% |
| 2011 Q2 | 14.4 Million BRL | 31.89% |
| 2011 Q1 | 10.91 Million BRL | -67.28% |
| 2011 FY | - BRL | 13.02% |
| 2011 Q3 | 15.35 Million BRL | 6.63% |
| 2010 FY | - BRL | -28.85% |
| 2010 Q4 | 33.36 Million BRL | 374.03% |
| 2010 Q3 | 7.03 Million BRL | -74.0% |
| 2010 Q2 | 27.06 Million BRL | 51.02% |
| 2010 Q1 | 17.92 Million BRL | -36.06% |
| 2009 Q4 | 28.03 Million BRL | -5.05% |
| 2009 FY | - BRL | 22.77% |
| 2009 Q3 | 29.52 Million BRL | -14.88% |
| 2009 Q2 | 34.68 Million BRL | 104.66% |
| 2009 Q1 | 16.94 Million BRL | -38.59% |
| 2008 Q3 | 24.6 Million BRL | 0.0% |
| 2008 FY | - BRL | -5.82% |
| 2008 Q4 | 27.59 Million BRL | 12.18% |
| 2007 FY | - BRL | 63.69% |
| 2006 FY | - BRL | 9.27% |
| 2005 FY | - BRL | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|